Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Francis E Jr Odonnell. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Francis E Jr Odonnell har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:INTI / Inhibitor Therapeutics, Inc. | See Remarks, Director, 10% Owner | 85 627 069 |
US:BDSI / Biodelivery Sciences International | Director | 0 |
US:ABPI / | Director | 1 960 992 |
FORMER DIRECTOR/EXEC. CHAIRMAN, Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Francis E Jr Odonnell. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp INTI / Inhibitor Therapeutics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i INTI / Inhibitor Therapeutics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel INTI / Inhibitor Therapeutics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i INTI / Inhibitor Therapeutics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2016-06-15 | HPPI | ODONNELL FRANCIS E JR | 2 560 000 | 2 560 000 | 0 | 0.1531 |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Francis E Jr Odonnell som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-12-22 | 3 | INTI |
Inhibitor Therapeutics, Inc.
Common Stock |
85 627 069 | ||||||||
2020-05-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −22 500 | 0 | −100,00 | ||||
2020-05-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 22 500 | 628 038 | 3,72 | ||||
2020-05-08 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −11 250 | 605 538 | −1,82 | 4,53 | −50 962 | 2 743 087 |
2020-05-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −16 000 | 616 788 | −2,53 | 4,45 | −71 200 | 2 744 707 |
2020-04-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 632 788 | −3,06 | 4,22 | −84 400 | 2 670 365 |
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −30 500 | 656 072 | −4,44 | 3,63 | −110 715 | 2 381 541 |
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 0 | −100,00 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −38 750 | 686 572 | −5,34 | 3,60 | −139 500 | 2 471 659 |
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 18 284 | 725 322 | 2,59 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 15 000 | 700 470 | 2,19 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 688 754 | 2,23 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 62 500 | 673 754 | 10,22 | ||||
2020-03-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 611 254 | 11,39 | ||||
2020-02-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 548 754 | −1,44 | 5,31 | −42 480 | 2 913 884 |
2020-01-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 556 754 | −1,42 | 6,10 | −48 800 | 3 396 199 |
2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −10 000 | 564 754 | −1,74 | 7,00 | −70 000 | 3 953 278 | |
2019-12-31 |
|
4/A | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 10 000 | 574 754 | 1,77 | 1,96 | 19 600 | 1 126 518 | |
2019-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −10 000 | 554 754 | −1,77 | 7,00 | −70 000 | 3 883 278 |
2019-12-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 564 754 | −1,40 | 6,86 | −54 880 | 3 874 212 |
2019-11-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 572 754 | −1,38 | 5,83 | −46 640 | 3 339 156 |
2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | −32 500 | 0 | −100,00 | ||||
2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −32 500 | 580 754 | −5,30 | 6,00 | −195 000 | 3 484 524 |
2019-10-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | X | 32 500 | 613 254 | 5,60 | 3,47 | 112 775 | 2 127 991 |
2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy) |
M - Exercise | X | −32 500 | 0 | −100,00 | |||
2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −32 500 | 580 754 | −5,30 | 5,00 | −162 500 | 2 903 770 |
2019-10-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | X | 32 500 | 613 254 | 5,60 | 2,26 | 73 450 | 1 385 954 |
2019-10-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 580 754 | −1,36 | 4,34 | −34 720 | 2 520 472 |
2019-09-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 588 754 | −1,34 | 4,29 | −34 320 | 2 525 755 |
2019-08-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 596 754 | −1,32 | 3,82 | −30 560 | 2 279 600 |
2019-07-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 604 754 | −1,31 | 4,68 | −37 440 | 2 830 249 |
2019-06-05 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 612 754 | −1,29 | 4,32 | −34 560 | 2 647 097 |
2019-05-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −22 500 | 22 500 | −50,00 | ||||
2019-05-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 22 500 | 620 754 | 3,76 | ||||
2019-05-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 598 254 | −1,32 | 4,77 | −38 160 | 2 853 672 |
2019-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (Right to Buy) |
A - Award | 22 500 | 22 500 | |||||
2019-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 45 000 | 45 000 | |||||
2019-04-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 606 254 | −1,30 | 5,19 | −41 520 | 3 146 458 |
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −71 690 | 614 254 | −10,45 | 5,21 | −373 505 | 3 200 263 |
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −9 757 | 0 | −100,00 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −15 000 | 0 | −100,00 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −15 000 | 30 000 | −33,33 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −62 500 | 0 | −100,00 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 62 500 | −50,00 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 9 757 | 685 944 | 1,44 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 15 000 | 676 187 | 2,27 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 661 187 | 2,32 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 62 500 | 646 187 | 10,71 | ||||
2019-03-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 583 687 | 11,99 | ||||
2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 0 | −100,00 | ||||
2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −23 000 | 521 187 | −4,23 | 5,07 | −116 610 | 2 642 418 |
2019-03-01 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 544 187 | 9,23 | ||||
2019-02-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 498 187 | −1,58 | 4,60 | −36 800 | 2 291 660 |
2019-01-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 506 187 | −1,56 | 3,64 | −29 120 | 1 842 521 |
2018-12-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 514 187 | −1,53 | 3,72 | −29 760 | 1 912 776 |
2018-11-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 522 187 | −1,51 | 3,84 | −30 720 | 2 005 198 |
2018-10-03 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 530 187 | −1,49 | 2,75 | −22 000 | 1 458 014 |
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −53 438 | 0 | −100,00 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −62 500 | 125 000 | −33,33 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 46 000 | −50,00 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −6 806 | 0 | −100,00 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −84 372 | 538 187 | −13,55 | 2,84 | −239 616 | 1 528 451 |
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 53 438 | 622 559 | 9,39 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 62 500 | 569 121 | 12,34 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 506 621 | 9,99 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 6 806 | 460 621 | 1,50 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 333 | 0 | −100,00 | ||||
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −66 667 | 453 815 | −12,81 | 2,83 | −188 668 | 1 284 296 |
2018-09-14 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 333 | 520 482 | 34,44 | ||||
2018-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −8 000 | 387 149 | −2,02 | 2,79 | −22 320 | 1 080 146 |
2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −37 500 | 0 | −100,00 | ||||
2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −27 525 | 395 149 | −6,51 | 3,10 | −85 328 | 1 224 962 | |
2018-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 37 500 | 422 674 | 9,74 | 2,01 | 75 375 | 849 575 | |
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 333 | 133 333 | −50,00 | ||||
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −66 666 | 385 174 | −14,75 | 2,14 | −142 665 | 824 272 |
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 333 | 451 840 | 41,86 | ||||
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −46 000 | 92 000 | −33,33 | ||||
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 418 | 0 | −100,00 | ||||
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −47 210 | 318 507 | −12,91 | 2,13 | −100 557 | 678 420 |
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 46 000 | 365 717 | 14,39 | ||||
2018-03-09 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 418 | 319 717 | 17,85 | ||||
2018-02-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 45 000 | 45 000 | |||||
2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −750 | 271 299 | −0,28 | 1,90 | −1 425 | 515 468 |
2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −2 520 | 0 | −100,00 | ||||
2017-03-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 2 520 | 272 049 | 0,93 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −6 416 | 269 529 | −2,33 | 1,85 | −11 870 | 498 629 |
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −83 900 | 275 945 | −23,32 | 1,89 | −158 571 | 521 536 |
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −133 334 | 266 666 | −33,33 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 419 | 48 418 | −50,00 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −70 000 | 0 | −100,00 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | −7 965 | 0 | −100,00 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −39 544 | 359 845 | −9,90 | 1,95 | −77 111 | 701 698 |
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 133 334 | 399 389 | 50,12 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 419 | 266 055 | 22,25 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 70 000 | 217 636 | 47,41 | ||||
2017-02-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 7 965 | 147 636 | 5,70 | ||||
2017-02-08 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 187 500 | 187 500 | |||||
2016-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 285 490 | −3,74 | 2,68 | −134 000 | 3 445 113 | |
2016-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 335 490 | −3,61 | 2,45 | −122 500 | 3 271 950 | |
2016-06-20 |
|
4/A | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
P - Purchase | 2 560 000 | 16 560 000 | 18,29 | ||||
2016-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −300 000 | 1 385 490 | −17,80 | ||||
2016-06-17 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
S - Sale | −2 560 000 | 11 440 000 | −18,29 | ||||
2016-06-08 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | −6 000 000 | 14 000 000 | −30,00 | ||||
2016-03-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Options |
M - Exercise | −15 000 | 10 000 | −60,00 | ||||
2016-03-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 15 000 | 139 671 | 12,03 | 2,05 | 30 750 | 286 326 | |
2016-03-02 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 138 000 | 138 000 | |||||
2015-12-24 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −200 000 | 1 685 490 | −10,61 | ||||
2015-11-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 885 490 | −2,58 | 6,01 | −300 500 | 11 331 795 | |
2015-11-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −20 000 | 124 671 | −13,82 | 6,00 | −120 000 | 748 026 | |
2015-09-14 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
P - Purchase | 20 000 000 | 20 000 000 | |||||
2015-09-04 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 144 671 | −12,15 | 6,43 | −128 600 | 930 235 |
2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −11 557 | 164 671 | −6,56 | 6,36 | −73 503 | 1 047 308 | |
2015-08-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 25 000 | 176 228 | 16,53 | 2,94 | 73 500 | 518 110 | |
2015-06-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −15 000 | 1 935 490 | −0,77 | ||||
2015-06-18 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 1 950 490 | −2,50 | 8,03 | −401 500 | 15 662 435 | |
2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 151 228 | −11,68 | 8,03 | −160 600 | 1 214 361 |
2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −1 597 | 171 228 | −0,92 | 7,97 | −12 728 | 1 364 687 |
2015-06-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 4 105 | 172 825 | 2,43 | ||||
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 400 000 | 400 000 | |||||
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −20 000 | 168 720 | −10,60 | 14,56 | −291 200 | 2 456 563 |
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −48 419 | 96 837 | −33,33 | ||||
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 48 419 | 188 720 | 34,51 | ||||
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
M - Exercise | −70 000 | 70 000 | −50,00 | ||||
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −35 000 | 140 301 | −19,97 | 14,37 | −502 950 | 2 016 125 |
2015-02-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 70 000 | 175 301 | 66,48 | ||||
2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 855 | 105 301 | 0,82 | ||||
2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 145 256 | 145 256 | |||||
2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
J - Other | −70 000 | 140 000 | −33,33 | ||||
2015-02-13 |
|
5 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units |
A - Award | 210 000 | 210 000 | |||||
2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −20 000 | 105 301 | −15,96 | 11,96 | −239 200 | 1 259 400 | |
2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 000 490 | −2,44 | 12,01 | −600 500 | 24 025 885 | |
2014-12-30 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −200 000 | 2 050 490 | −8,89 | ||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
J - Other | 18 984 | 64 034 | 42,14 | ||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
J - Other | 4 012 | 13 532 | 42,14 | ||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Warrant to purchase Common Stock |
J - Other | 2 716 401 | 2 716 401 | |||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Warrant to purchase Common Stock |
J - Other | 574 032 | 574 032 | |||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 670 510 | 670 510 | |||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 141 693 | 141 693 | |||||
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 5 300 000 | 5 970 510 | 790,44 | 0,08 | 397 500 | 447 788 | |
2014-07-09 |
|
4 | HPPI |
HedgePath Pharmaceuticals, Inc.
Common Stock, $.0001 par value per share |
J - Other | 1 120 000 | 1 261 693 | 790,44 | 0,08 | 84 000 | 94 627 | |
2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −35 000 | 0 | −100,00 | ||||
2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −6 815 | 2 375 791 | −0,29 | 11,76 | −80 144 | 27 939 302 | |
2014-06-27 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 35 000 | 2 382 606 | 1,49 | 2,29 | 80 150 | 5 456 168 | |
2014-06-13 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −125 000 | 2 347 606 | −5,06 | 11,04 | −1 380 000 | 25 917 570 | |
2014-03-28 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 472 606 | −1,98 | 8,04 | −402 000 | 19 879 752 | |
2014-02-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | X | −70 000 | 2 521 751 | −2,70 | 8,92 | −624 400 | 22 494 019 |
2014-02-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 70 000 | 2 591 751 | 2,78 | 8,90 | 623 000 | 23 066 584 | |
2014-01-17 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 521 751 | −3,81 | 6,01 | −601 000 | 15 155 724 | |
2014-01-10 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 621 751 | −3,67 | 6,20 | −620 000 | 16 254 856 | |
2013-12-26 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 2 721 751 | −1,80 | 5,88 | −294 000 | 16 003 896 | |
2013-12-26 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 771 751 | −3,48 | 5,91 | −591 000 | 16 381 048 | |
2013-12-06 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 871 751 | −3,37 | 5,30 | −530 000 | 15 220 280 | |
2013-11-15 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 2 971 751 | −3,26 | 4,44 | −444 000 | 13 194 574 | |
2013-11-12 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −1 375 000 | 1 960 992 | −41,22 | 0,01 | −13 750 | 19 610 | |
2013-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −50 000 | 3 071 751 | −1,60 | 5,37 | −268 500 | 16 495 303 | |
2013-09-23 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −45 000 | 3 121 751 | −1,42 | 5,35 | −240 750 | 16 701 368 | |
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −459 550 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −1 950 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −125 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −1 000 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −75 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −60 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
J - Other | −40 000 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −281 250 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −414 545 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −84 951 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −111 610 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −2 991 | 0 | −100,00 | ||||
2013-08-23 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
J - Other | −18 306 | 0 | −100,00 | ||||
2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −8 891 | 0 | −100,00 | ||||
2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option |
M - Exercise | −26 109 | 0 | −100,00 | ||||
2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
F - Taxes | −30 466 | 3 166 751 | −0,95 | 4,40 | −134 050 | 13 933 704 | |
2013-08-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
M - Exercise | 35 000 | 3 197 217 | 1,11 | 3,83 | 134 050 | 12 245 341 | |
2013-08-16 |
|
4 | CBTEQ |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
A - Award | 45 050 | 45 050 | |||||
2013-08-16 |
|
4 | CBTEQ |
HedgePath Pharmaceuticals, Inc.
Series A Convertible Preferred Stock |
A - Award | 9 520 | 9 520 | |||||
2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −34 258 | 3 162 217 | −1,07 | 4,27 | −146 282 | 13 502 667 | |
2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −14 242 | 3 196 475 | −0,44 | 4,36 | −62 095 | 13 936 631 | |
2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −1 500 | 3 210 717 | −0,05 | 4,45 | −6 675 | 14 287 691 | |
2013-06-21 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
S - Sale | −22 689 | 3 212 217 | −0,70 | 4,50 | −102 100 | 14 454 976 | |
2013-06-07 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
A - Award | 1 727 | 3 234 906 | 0,05 | 4,30 | 7 426 | 13 910 096 | |
2013-04-19 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 3 075 490 | −3,15 | ||||
2012-10-26 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −500 000 | 3 335 992 | −13,03 | ||||
2012-06-22 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock |
J - Other | −100 000 | 3 175 490 | −3,05 | ||||
2012-06-15 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Warrant (Right to Buy) |
J - Other | −125 000 | 414 545 | −23,17 | ||||
2012-04-13 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −100 000 | 3 835 992 | −2,54 | 0,37 | −37 000 | 1 419 317 | |
2012-04-03 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 459 550 | 459 550 | |||||
2012-03-13 |
|
4 | BDSI |
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2012-03-02 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 300 000 | 300 000 | |||||
2012-02-17 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −125 000 | 3 935 992 | −3,08 | ||||
2012-02-17 |
|
4 | ABPI |
ACCENTIA BIOPHARMACEUTICALS INC
Common Stock |
J - Other | −375 000 | 0 | −100,00 | ||||
2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock Purchase Warrant |
M - Exercise | −590 909 | 0 | −100,00 | ||||
2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
F - Taxes | −497 604 | 217 858 | −69,55 | 0,38 | −189 090 | 82 786 | |
2012-01-19 |
|
4 | BVTI.OB |
BIOVEST INTERNATIONAL INC
Common Stock |
M - Exercise | 590 909 | 715 462 | 474,42 | 0,32 | 189 091 | 228 948 |